Neurogene Inc.

Neurogene Inc.

NGNE · Nasdaq

Neurogene Inc. (NGNE) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Neurogene Inc. in 2026. The next earnings report is expected on November 23, 2026.

Earnings calendar

Next earnings date

23 Nov 2026

In 95 days

EPS estimate

-1.35

Revenue estimate

0

Past earnings

11 Aug 2026
EPS actual
-1.53 (-7.5%)
estimate -1.42
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-1.39 (-7.2%)
estimate -1.30
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
24 Mar 2026
EPS actual
-1.12 (+9.6%)
estimate -1.24
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 Nov 2025
EPS actual
-0.99 (+20.8%)
estimate -1.25
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Neurogene Inc. missed consensus estimates in its latest earnings report, with EPS of -$1.53 versus an expected -$1.4233, while revenue of $0 met the $0 estimate. In the prior report, EPS also missed expectations and revenue likewise met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Rachel L. McMinn
Employees
107
IPO date
07 Mar 2014
ISIN
US64135M1053
Website
neurogene.com

Frequently asked questions

When does Neurogene Inc. (NGNE) next report earnings?

Neurogene Inc. (NGNE) is scheduled to report earnings on November 23, 2026.

What was Neurogene Inc.'s most recent earnings date?

Neurogene Inc. (NGNE) last reported earnings on August 11, 2026.

Where is Neurogene Inc. stock listed?

Neurogene Inc. (NGNE) is listed on Nasdaq.